Drug Wholesale Price Plaintiffs Eye Later Judgment
In the wake of a June ruling that AstraZeneca, Bristol-Myers Squibb and Schering-Plough Corp. inflated average wholesale prices of drugs, plaintiffs have asked the court to decide whether to grant treble...To view the full article, register now.
Already a subscriber? Click here to view full article